MedTrace Logo

Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System

NCT01785446 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-02-07

No results posted yet for this study

Summary

The purpose of this study is to:

* determine the effect of dexmedetomidine on cisatracurium infusion requirements and sufentanil consumption.
* analyze the cisatracurium infusion requirements and sufentanil consumption in different age groups.

Conditions

  • The Intraoperative Effect of Dexmedetomidine on Cisatracurium Infusion Consumption and Its Recovery Index.
  • Effect of Dexmedetomidine on Sufentanil Consumption.
  • Quantitative Analysis of Cisatracurium Infusion Requirements, Sufentanil Consumption and Recovery Index in Different Age Groups.

Interventions

DRUG

Effect of dexmedetomidine on cisatracurium and sufentanil consumption

In this intervention we compared the cisatracurium consumption, recovery index and sufentanil consumption between P2 and D. The reason we are comparing patients in group D with P2 is that because they belong to the same age group.

DRUG

Consumption of cisatracurium and sufentanil in different age groups.

For this intervention, we compared the cisatracurium consumption, refractory index and sufentanil consumption between group P1, P2 and P3.

Sponsors & Collaborators

  • Shehzaad Joomye

    collaborator UNKNOWN

  • Haiyun Wang

    collaborator UNKNOWN

  • Donglai Yan

    collaborator UNKNOWN

  • Tianjin Medical University General Hospital

    lead OTHER

Principal Investigators

  • Guolin Wang, MD, PhD, Professor · Tianjin Medical University General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01785446 on ClinicalTrials.gov